Torsten Doenst

Cardiac surgery is thinking with your hands

[Torsten Doenst @ToDoenst]

@LucianoHangBr Luciano, welcome to Germany. Have fun in Munich. 😎🍺🍺🍺

[Dmytro Babliak, MD, PhD @BabliakD]

Strong International Hearts — Berlin 🇩🇪
36 hours of nonstop training —challenging, and incredibly effective.
Huge thanks to Prof. @ToDoenst, @HrisKirov, and @TulioCaldonazo for this outstanding program, and to Prof. Cristian Heim and my teammate Nadine Emmerich for great teamwork

[Xander Jacquemyn @XanderJacquemyn]

👵👴Frail and older adults remain underrepresented in revascularization trials. @HrisKirov presents rationale and design of CAB-AGE I Trial, with frailty as primary outcome after PCI vs CABG. Potential CAB-AGE II will target 5-yr hard clinical endpoints. @ToDoenst @ISCAScoronary

[Xander Jacquemyn @XanderJacquemyn]

🔑 Fascinating keynote talks today at @ISCAScoronary: From a deep dive into how CABG and PCI truly differ, physiologically, pathologically, and clinically from @ToDoenst to an eye-opening look at the controversy shaping modern coronary trials @FaisalBakaeen @GianTorre610

[Faisal Bakaeen MD @FaisalBakaeen]

NOBLEty and FAME to PCI not CABG: Not Based on Scientific Credentials - https://t.co/vKTstrMFvZ

[Gianluca Torregrossa @GianTorre610]

Please join me this Saturday at 8 AM EDT Time for another @ISCAScoronary Morning Talk about #OffPump #CABG How to learn it. Togehter with collegues and friends we will discuss how to become proficient in Off Pump. Event supported by @Medtronic

https://t.co/NXjFVENOo7

[Torsten Doenst @ToDoenst]

@drjohnm @HrisKirov @divaka_perera If we keep calling PCI and CABG revascularization, we will keep blurring our perception of outcomes, because we do not understand the underlying treatment mechanisms (https://t.co/gM9qSccvnc).

[ISCAS @ISCAScoronary]

👉 Want to learn more?

Join us at the International Coronary Congress (ICC), New York, December 2025.

Where science meets innovation in coronary surgery!

[Victor Dayan @VictorDayan1]

🚑BREAKING NEWS. This is massive. 10 year PARTNER 2 data has been released by the company. No statistical analyses were performed. But I performed them and these is what happened at 10 years. @pomyers @rafasadaba @STS_CTsurgery @EACTS

[Hristo Kirov @HrisKirov]

15 surgeons. 5 countries. 1 mission:
advancing minimally invasive cardiac surgery.

A week of live cases, wetlabs & lectures at the Jena MICS Bootcamp = new skills, knowledge & network

The winners? Our patients. Like 2x full-arterial, off-pump, no-touch-aorta MICS-CABG 🫀

[Torsten Doenst @ToDoenst]

Do you know what revascularization really means?

https://t.co/IzSGehNhbO

[Torsten Doenst @ToDoenst]

JenaMICS Bootcamp 2025 on German Television 👍 https://t.co/4TkST9z6gy

[Hristo Kirov @HrisKirov]

What if the best vaccine against heart attacks… is surgery? 🫀

CABG cuts MI risk by 51% — on par with approved vaccines.

It doesn’t just treat — it prevents. A collateral prevention system for the heart.

🧠💉 Read more: https://t.co/7taDzAbcCx

[Robert Greene @RobertGreene]

Skill and competence are far more important than friendly feelings.

[Torsten Doenst @ToDoenst]

UKJ | Around the world, around the woorld 🌎 – geht der „Jena Style“ unserer Herzchirurgie: Brasilien 🇧🇷, Mexiko 🇲🇽, Südafrika 🇿🇦, Chile 🇨🇱,... | Instagram https://t.co/KImITvgRj2

[Torsten Doenst @ToDoenst]

@gerchaud @HrisKirov @TulioCaldonazo @CardiocirugiaHH Germán, looking good…. not just the cap🙂

[Torsten Doenst @ToDoenst]

Lifetime management of heart valve disease—treat it early and treat it right, first time - The Lancet https://t.co/Td0PE78GWa

[Torsten Doenst @ToDoenst]

@FaisalBakaeen @VictorDayan1 @mmamas1973 @DavidLBrownMD @pomyers @rafasadaba Yes, but here is why https://t.co/CTH7kHPP6Q 🙂

[Torsten Doenst @ToDoenst]

@pash22 @pomyers @djc795 @FaisalBakaeen @Coronary4front @agtruesdell @JoeSabik @VictorDayan1 @RuelMarc1 @GianTorre610 @HrisKirov @RakanINazer @rahatheart1 @rafasadaba @Dr_Ma_of_PUMC @FarivarRobert @sloaneguy @JoChikweMD @DrNivAd @Shahzad77891064 @TomVargheseJr @AortaSurg @loremontesvilla The problem is not operating based on CT. That is easy. The problem is optimal decision-making for CABG because CT currently tends to overestimate CAD severity. So, no problem with Syntax >40 or so, but tricky when intermediate.

[Torsten Doenst @ToDoenst]

@georgetolisjr True, but how do you explain that practically no trial comparing new therapies with the non-evidence based surgical procedures shows superiority?